Please assess the completion status of the following clinical trial:

Trial Title: Long Term Nebulised Gentamicin in Patients With Bronchiectasis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Bronchiectasis confirmed by HRCT of the chest~* Clinically stable (not requiring antibiotics for at least 4 weeks preceding the study start date)~* Aged 18-70~* Chronic sputum production \> 5 mls for the majority of days in 3 months before enrolment~* Chronically colonized (on at least 2 occasions in the preceding 12 months) whilst clinically stable~* At least two exacerbations in the past year~* Patients able to tolerate a nebulized gentamicin challenge~* FEV1 \> 30% predicted~* Smoking \< 20 pack year history and ex-smokers \>1 year.~Exclusion Criteria:~* Cystic fibrosis~* Emphysema on HRCT chest~* Thoracic surgery within the past 1 year~* Allergic bronchopulmonary aspergillosis~* Poorly controlled asthma ( \> 20% diurnal variation in peak expiratory flows despite treatment)~* Unstable angina or uncontrolled congestive cardiac failure~* Active malignancy~* Pregnancy or breast feeding~* Creatinine clearance \< 30 mls/minute~* Vestibular instability~* Previous documented intolerance to aminoglycosides

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Nebulised Gentamicin
- 2 (Type: PLACEBO_COMPARATOR): Nebulised 0.9% Saline

Based on this trial design, predict the completion outcome and termination type (if applicable).